(Q46757968)

24 December 2017

title

Procholinergic and memory enhancing properties of the selective norepinephrine uptake inhibitor atomoxetine (English)

1 reference

24 December 2017

0 references

Tzavara ET

1

1 reference

24 December 2017

Bymaster FP

2

1 reference

24 December 2017

Overshiner CD

3

1 reference

24 December 2017

Davis RJ

4

1 reference

24 December 2017

Perry KW

5

1 reference

24 December 2017

Wolff M

6

1 reference

24 December 2017

McKinzie DL

7

1 reference

24 December 2017

Witkin JM

8

1 reference

24 December 2017

Nomikos GG

9

1 reference

24 December 2017

language of work or name

English

0 references

publication date

1 February 2006

1 reference

24 December 2017

published in

Molecular Psychiatry

1 reference

24 December 2017

volume

11

1 reference

24 December 2017

issue

2

1 reference

24 December 2017

page(s)

187-195

1 reference

24 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.mp.4001763

exact match

0 references

cites work

Atomoxetine hydrochloride for the treatment of attention-deficit/hyperactivity disorder

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Nonstimulant treatment of adult attention-deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Central cholinergic systems and cognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Atypical, but not typical, antipsychotic drugs increase cortical acetylcholine release without an effect in the nucleus accumbens or striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Effects of typical and atypical antipsychotics and receptor selective compounds on acetylcholine efflux in the hippocampus of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: a potential mechanism for efficacy in attention deficit/hyperactivity disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Basal acetylcholine release in freely moving rats detected by on-line trans-striatal dialysis: pharmacological aspects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

SR141716A, a cannabinoid CB1 receptor antagonist, improves memory in a delayed radial maze task

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Facilitation of glutamate receptors enhances memory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Effects of D-cycloserine, a positive modulator of N-methyl-D-aspartate receptors, and ST 587, a putative alpha-1 adrenergic agonist, individually and in combination, on the non-delayed and delayed foraging behaviour of rats assessed in the radial ar

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

A new one-trial test for neurobiological studies of memory in rats. 1: Behavioral data

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Effects of physostigmine and scopolamine on rats' performances in object-recognition and radial-maze tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Effect of sympathomimetic amines on the synaptosomal transport of noradrenaline, dopamine and 5-hydroxytryptamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Dopaminergic regulation of cortical acetylcholine release.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Direct catecholaminergic-cholinergic interactions in the basal forebrain. I. Dopamine-beta-hydroxylase- and tyrosine hydroxylase input to cholinergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition, and treatment strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Dysregulated hippocampal acetylcholine neurotransmission and impaired cognition in M2, M4 and M2/M4 muscarinic receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Executive and social behaviors under nicotinic receptor regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Effect of histamine H2 and H3 receptor modulation in the septum on post-training memory processing.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Effects of acute nicotine on several operant behaviors in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Effects of scopolamine and D-cycloserine on non-spatial reference memory in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

D1 dopamine receptors in the mouse prefrontal cortex: Immunocytochemical and cognitive neuropharmacological analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Memory improvement without toxicity during chronic, low dose intravenous arecoline in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer's disease. Eptastigmine Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

Chronic lithium attenuates dopamine D1-receptor mediated increases in acetylcholine release in rat frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

7 January 2021

Local influence of endogenous norepinephrine on extracellular dopamine in rat medial prefrontal cortex

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

7 January 2021

Neurotransmitter systems involved in learning and memory in the rat: a meta-analysis based on studies of four behavioral tasks

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

7 January 2021

Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.MP.4001763

7 January 2021

Identifiers

DOI

10.1038/SJ.MP.4001763

1 reference

24 December 2017

PubMed ID

16231039

1 reference

24 December 2017